Consensus clustering was used to divide BA patients in the GSE46960 dataset into two groups: cluster 1 (low expression of SMAD3, high expression of PPARα and NR1H4) and cluster 2 (high expression of SMAD3, low expression of PPARα and NR1H4). This evidence concerns the gene NR1H4 and breast angiosarcoma.